The Joint Corp. develops, owns, operates, supports, and manages chiropractic clinics. The company operates in two segments, Corporate Clinics and Franchise Operations. It operates through direct ownership, management arrangements, franchising, and regional developers. As of March 1, 2022, the company operated approximately 700 locations in the United States. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Joint Stock Up 1.7 %
Shares of NASDAQ:JYNT opened at $21.61 on Friday. The company has a quick ratio of 0.87, a current ratio of 0.87 and a debt-to-equity ratio of 0.07. The company has a market capitalization of $312.41 million, a P/E ratio of 144.04 and a beta of 1.33. Joint has a 52-week low of $13.10 and a 52-week high of $111.06. The stock's fifty day simple moving average is $16.74 and its 200-day simple moving average is $27.28.
Wall Street Analyst Weigh In
JYNT has been the topic of a number of recent analyst reports. Lake Street Capital lowered their price target on shares of Joint from $100.00 to $50.00 in a research note on Friday, May 6th. Craig Hallum downgraded shares of Joint from a "buy" rating to a "hold" rating and reduced their price target for the company from $90.00 to $30.00 in a research report on Friday, May 6th. Roth Capital decreased their price target on Joint from $75.00 to $40.00 in a research note on Monday, May 9th. StockNews.com cut Joint from a "hold" rating to a "sell" rating in a report on Friday, August 12th. Finally, B. Riley raised Joint from a "neutral" rating to a "buy" rating and set a $31.00 target price on the stock in a report on Friday, August 5th. Two investment analysts have rated the stock with a sell rating, one has issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $33.17.
Insider Activity at Joint
In other news, major shareholder Bandera Partners Llc purchased 6,593 shares of the firm's stock in a transaction on Monday, June 13th. The shares were bought at an average cost of $13.86 per share, with a total value of $91,378.98. Following the purchase, the insider now directly owns 2,111,868 shares of the company's stock, valued at $29,270,490.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. 3.50% of the stock is currently owned by corporate insiders.